YIFAN PHARMACEUTICAL CO (SZSE:002019) Forward Dividend Yield % : 0.00% (As of May. 26, 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Forward Dividend Yield %?

As of today (2024-05-26), the Forward Annual Dividend Yield of YIFAN PHARMACEUTICAL CO is 0.00%.

As of today (2024-05-26), the Trailing Annual Dividend Yield of YIFAN PHARMACEUTICAL CO is 0.00%.

SZSE:002019's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful Forward Dividend Yield % only.

YIFAN PHARMACEUTICAL CO's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of YIFAN PHARMACEUTICAL CO was 115.40% per year. The lowest was -50.00% per year. And the median was 29.85% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Forward Dividend Yield %

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YIFAN PHARMACEUTICAL CO's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Forward Dividend Yield % falls into.

YIFAN PHARMACEUTICAL CO Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

YIFAN PHARMACEUTICAL CO Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

Executives

Ye Yi Qun	Director
Zhang Da Wei	Executives
Geng Yu Hong	Executives
Feng De Qi	Directors, Directors, and Executives
Zhou Ben Yu	Director
Lin Xing	Directors, executives
Yu Hai Xia	Executives
Cheng Xian Feng	Directors, executives
Xu Guo Han	Supervisors
Cao Shi Mei	Director
Lin Guan Yu	Director
Zhang Lian Chun	Executives
Guo Xin Fu	Director
Zheng Shi Ming	Supervisors
Yin Hang Hua	Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines